IP
CRSP icon

Intellectus Partners’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$284K Buy
+5,845
New +$284K 0.06% 232
2025
Q1
Sell
-7,131
Closed -$281K 276
2024
Q4
$281K Buy
7,131
+250
+4% +$9.84K 0.06% 229
2024
Q3
$323K Buy
6,881
+125
+2% +$5.87K 0.08% 212
2024
Q2
$365K Sell
6,756
-1,245
-16% -$67.2K 0.1% 200
2024
Q1
$545K Sell
8,001
-705
-8% -$48.1K 0.14% 178
2023
Q4
$545K Buy
8,706
+150
+2% +$9.39K 0.16% 171
2023
Q3
$388K Buy
8,556
+650
+8% +$29.5K 0.12% 193
2023
Q2
$444K Buy
7,906
+50
+0.6% +$2.81K 0.13% 187
2023
Q1
$355K Buy
7,856
+200
+3% +$9.05K 0.11% 192
2022
Q4
$311K Sell
7,656
-364
-5% -$14.8K 0.11% 205
2022
Q3
$524K Sell
8,020
-820
-9% -$53.6K 0.19% 151
2022
Q2
$537K Sell
8,840
-1,050
-11% -$63.8K 0.18% 149
2022
Q1
$621K Sell
9,890
-1,000
-9% -$62.8K 0.19% 144
2021
Q4
$825K Sell
10,890
-280
-3% -$21.2K 0.21% 126
2021
Q3
$1.25M Buy
11,170
+125
+1% +$14K 0.3% 88
2021
Q2
$1.79M Buy
11,045
+875
+9% +$142K 0.4% 58
2021
Q1
$1.24M Buy
10,170
+1,200
+13% +$146K 0.34% 78
2020
Q4
$1.37M Sell
8,970
-475
-5% -$72.7K 0.41% 74
2020
Q3
$790K Buy
9,445
+370
+4% +$30.9K 0.3% 105
2020
Q2
$667K Buy
9,075
+30
+0.3% +$2.21K 0.26% 120
2020
Q1
$384K Buy
9,045
+2,325
+35% +$98.7K 0.18% 140
2019
Q4
$409K Buy
+6,720
New +$409K 0.17% 158
2019
Q2
Sell
-1,350
Closed -$48K 220
2019
Q1
$48K Buy
1,350
+850
+170% +$30.2K 0.02% 259
2018
Q4
$14K Hold
500
0.01% 188
2018
Q3
$22K Sell
500
-150
-23% -$6.6K 0.01% 409
2018
Q2
$38K Buy
+650
New +$38K 0.01% 363
2017
Q3
Sell
-425
Closed -$7K 759
2017
Q2
$7K Hold
425
﹤0.01% 621
2017
Q1
$9K Buy
425
+100
+31% +$2.12K ﹤0.01% 541
2016
Q4
$7K Buy
+325
New +$7K ﹤0.01% 555